In-Stent Restenosis in the United States: Time to Enrich its Treatment Armamentarium

J Am Coll Cardiol. 2020 Sep 29;76(13):1532-1535. doi: 10.1016/j.jacc.2020.08.035.

Authors

Adnan Kastrati¹, Salvatore Cassese²

Affiliations

¹ Klinik für Herz-und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: kastrati@dhm.mhn.de.
² Klinik für Herz-und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.

PMID: 32972529
DOI: 10.1016/j.jacc.2020.08.035

No abstract available

Keywords: drug-eluting stent; percutaneous coronary intervention; restenosis.

Publication types

Editorial
Comment

MeSH terms

Angioplasty, Balloon, Coronary*
Coronary Restenosis* / epidemiology
Coronary Restenosis* / therapy
Drug-Eluting Stents*
Humans
United States / epidemiology